Treatment of scleromyxedema with intravenous immunoglobulin

European Journal of Dermatology

Volumn 20, Issue 6, 2010, Pages 861-862

  Roque Diamantino, Filipa De Encarnação ^a   Lopes João, Alexandre Miguel Bruno ^a   Clemente Fidalgo, Ana Isabel Pina ^a   Taveira Lobo, Maria De Lurdes Leite ^a  

^a HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; HYDROXYZINE; IMMUNOGLOBULIN G; PARACETAMOL; IMMUNOGLOBULIN;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED HEADACHE; FEMALE; HUMAN; LABORATORY TEST; LETTER; MULTIPLE CYCLE TREATMENT; PUNCH BIOPSY; REMISSION; SCLEROMYXEDEMA; SKIN BIOPSY; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; SCLEROMYXEDEMA;

EID: 78649876203     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1100     Document Type: Letter

References (6)

1. Rongioletti F, Rebora A. Update classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-81. (Pubitemid 32172190)
2. Jeanmarie R, Rebecca L. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J Am Acad Dermatol 2009; 60: 1037-41.
3. Lister RK, Jolles S, Whittaker S, et al. Scleromyxedema: response to high dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43: 403-8.
4. Kulczychi A, Nelson M, Eisen A, et al. Scleromyxedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003; 149: 1276-81. (Pubitemid 38058107)
5. Sroa N, Campbell S, Betchtel M. Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature. J Drugs Dermatol 2010; 9: 263-5.
6. Eck A. Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. Eur J Dermatol 2009; 19: 90-8.